Establishment of a novel monoclonal antibody SMab-1 specific for IDH1-R132S mutationMika K. Kaneko, Yukinari Kato, Weidong Tian et al.|Biochemical and Biophysical Research Communications|2011Cited by 45
Randomized trial of chemoradiotherapy and adjuvant chemotherapy with nimustine (ACNU) versus nimustine plus procarbazine for newly diagnosed anaplastic astrocytoma and glioblastoma (JCOG0305)Soichiro Shibui, Kazuhiro Nomura, Yoshitaka Narita et al.|Cancer Chemotherapy and Pharmacology|2012Cited by 31
A high-sensitive HMab-2 specifically detects IDH1-R132H, the most common IDH mutation in gliomasYuki Fujii, Yukinari Kato, Satoshi Ogasawara et al.|Biochemical and Biophysical Research Communications|2015Cited by 13